Articles Tagged With: COVID-19
-
Want to Retain and Support Staff? Better Communication from Leadership Helps
Hospital nurses need effective communication from leadership to help them cope with the long COVID-19 pandemic, according to the results of a recent study. Nurses also need to be part of leadership gatherings, local meetings, and decision-making to share their daily experiences and help find solutions to the unprecedented emergencies created during the past two years. -
Care Transitions Are Trickier Than Ever as Pandemic Wreaks Havoc
The bottleneck of patients many health systems experienced in early winter was created by a perfect storm of these problems: too few employees, too many patients sick with the omicron variant, and too many ambulatory settings also experiencing staffing problems. -
Infection Prevention Tips for Omicron Variant
As omicron swept through the nation, creating chaos at hospitals, the Infectious Diseases Society of America made four major suggestions for how organizations and individuals can prevent infection and serious illness. -
Study Results Reveal How Hospitals Handled COVID-19’s First Wave
Healthcare systems’ responses to the first wave of the COVID-19 pandemic varied, but most canceled elective procedures to preserve ICU capacity and adapted staffing and physical space to prepare for patient surges, according to the results of a recent study. -
Omicron Created Problems of Too Few Staff, Too Many Patients, Too Much Distress
After two years of the COVID-19 pandemic, healthcare leaders know how to react and prepare. But with omicron, the earlier lessons learned were not enough to prevent patient surges and staffing shortages. -
Using Breathing Techniques for Exertion and Anxiety During COVID Lockdowns
In a small prospective study comparing four breathing techniques, the maximum statistically significant effect on reduced perceived exertion during breath-holding is associated with a yoga breathing method called anulom vilom pranayama (alternate nostril breathing).
-
The Effect of Disease-Modifying Therapies for Multiple Sclerosis on the Immune Responses to COVID-19 Vaccination
An analysis of a large group of patients with multiple sclerosis taking various disease-modifying therapies showed that the response to COVID-19 vaccination was not uniform across the therapies. Patients taking anti-CD20 therapies and fingolimod had attenuated responses to vaccines.
-
Infectious Disease Alert Updates
Mandating COVID-19 Vaccination for Healthcare Workers — Revisited; SARS-CoV-2 as a North American Zoonosis; VIRSTA vs. PREDICT in Predicting Endocarditis
-
COVID-19 Vaccination Prevents Systemic Inflammatory Syndrome (MIS-C)
The estimated effectiveness of two doses of Pfizer-BioNTech vaccine in the prevention of multisystem inflammatory syndrome in children was 91%.
-
COVID-19 Vaccination Is Life-Saving
This study confirms the effectiveness of COVID-19 vaccination in preventing severe outcomes between the end of 2020 and October 2021 (i.e., pre-omicron). Age, immunosuppression, and chronic disease were independent risk factors. In contrast to previous studies largely involving unvaccinated individuals, male sex and race/ethnicity were not.